Briefly

URUGUAY

Sinovac jab cuts adult deaths by 95%

The COVID-19 mortality rate among Uruguayans aged 18 to 69 who were vaccinated with Sinovac vaccine fell by more than 95 percent, the latest Vaccine Effectiveness report from the Public Health Ministry said. Two weeks after receiving the second dose of the CoronaVac vaccine, developed by Chinese drugmaker Sinovac Biotech, mortality fell by 95.3 percent among the vaccinated population aged 18 to 49.